Arata Tomiyama

7PUBLICATIONS
31CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 02, 2022
A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.

Kyuto Sonehara, Yui Kimura, Yoshiko Nakano

|Mar 28, 2022
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma.

Jo Sasame, Naoki Ikegaya, Masahito Kawazu

|Mar 17, 2021
The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death.

Daisuke Kawauchi, Masamichi Takahashi, Kaishi Satomi

Pageof 2